Combined legal notice (provider identification) under the Telemediengesetz (TMG, Electronic Information and Communication Services Act) and the Staatsvertrag für Rundfunk und Telemedien (RStV, State Treaty on Broadcasting and Electronic Information and Communication Services)
Medigene AG, represented by Executive Management Board members Prof. Dr. Dolores J. Schendel (Chief Executive Officer), Dr. Kai Pinkernell and Axel Sven Malkomes is the provider and therefore responsible for the commercial and business website within the meaning of Section 5 of the Telemediengesetz in its function as the core act under the Elektronischer-Geschäftsverkehr-Vereinheitlichungsgesetz (ElGVG, E-Commerce Standardization Act) and the Gesetz zur Regelung der Rahmenbedingungen für Informations- und Kommunikationsdienste (IuKDG, Act Regulating the Framework Conditions for Information and Communication Services).
This website is brought to you by:
Lochhamer Str. 11
Registered office of Medigene AG: D-82152 Planegg
District Court of Munich, HRB 115761
Legal form: joint stock company (AG)
Governing law: law of the Federal Republic of Germany (FRG)
Munich revenue office VAT number: DE 167 014 708
Executive Management Board members with powers of representation: Prof. Dr. Dolores J. Schendel (Chief Executive Officer), Dr. Kai Pinkernell, Axel Sven Malkomes
Chamber of Industry and Commerce for Munich and Upper Bavaria
Balanstraβe 55 - 59
D-81541 Munich, Germany
Telephone: +49 89 5116-0
Fax: +49 89 5116-1306
Information regarding the settlement of online disputes pursuant to Article 14 (1) ODR-VO (Online Dispute Resolution Regulation):
The European Commission makes available a platform for online dispute resolution at http://ec.europa.eu/consumers/odr. This platform is designed to be a contact point for out-of-court settlement of disputes regarding contractual obligations arising from online sale and purchase agreements.
We are neither obliged nor willing to participate in dispute resolution before a consumer mediation service.
Responsible for editorial content pursuant to Section 55 (2) of the Staatsvertrag für Rundfunk und Telemedien (RStV, State Treaty on Broadcasting and Electronic Information and Communication Services):
Dr. Gary Waanders, Head of Investor Relations, E-Mail: investor(at)medigene.com
Lochhamer Straβe 11, D-82152 Planegg, Germany
External data protection officer pursuant to Article 37 DSGVO in conjunction with § 38 Abs. 1 BDSG-neu (BDSG, German Data Protection Act):
Deutsche Datenschutzkanzlei - Datenschutzkanzlei Lenz GmbH & Co. KG
Technical support and design of this website:
Kirchhoff Consult AG, Borselstraβe 20, D-22765 Hamburg, Germany
Telephone: +49 40 609186-0, email: info(at)kirchhoff.de
Features of Medigene AG’s services
Direct or indirect activities related to the development and marketing of, in particular, molecular biology technologies, methods and products in the sector of drugs, active pharmaceutical ingredients and the relevant intermediate products, as well as delivery of associated services. The Company may pursue its business purpose itself or via subsidiaries and affiliated companies.
Medigene AG may change all or parts of this website anytime without prior announcement at its discretion, or close it down, without assuming liability. Creating links to third party websites (hyperlinks) does not mean that Medigene AG is responsible for such websites or their content. Furthermore, Medigene AG is not responsible for the availability of such websites or their content.
All rights reserved. Text, pictures and graphics as well as their formatting on the website are subject to copyright law and other protective laws. The content of this website must not be copied, disseminated, changed or made available to third parties for commercial purposes.
Copyright – picture sources:
Oliver Tjaden, Matthias Tunger, Kirchhoff Consult, Medigene AG
NB: Allgemeines Gleichbehandlungsgesetz (AGG, General Act on Equal Treatment Act)
In order to facilitate readability, gender-neutral language is used. The relevant terms apply to both genders in line with equal treatment.